Nasopharyngeal carcinoma
Epidemiological trends during the past decade suggest that although incidence of
nasopharyngeal carcinoma is gradually declining, even in endemic regions, mortality from the …
nasopharyngeal carcinoma is gradually declining, even in endemic regions, mortality from the …
Phase separation of signaling molecules promotes T cell receptor signal transduction
… S1, E and F). pLAT also clustered with Gads and SLP-76, two other components of LAT … (E)
(Left) TIRF microscopy images of His 10 -Nck-Pacific Blue and actin-rhodamine on the bilayer…
(Left) TIRF microscopy images of His 10 -Nck-Pacific Blue and actin-rhodamine on the bilayer…
Nasopharyngeal carcinoma: an evolving paradigm
The past three decades have borne witness to many advances in the understanding of the
molecular biology and treatment of nasopharyngeal carcinoma (NPC), an Epstein–Barr virus (…
molecular biology and treatment of nasopharyngeal carcinoma (NPC), an Epstein–Barr virus (…
T cell costimulatory receptor CD28 is a primary target for PD-1–mediated inhibition
… Second, this work provides an explanation for the synergy observed in our studies between
PD-1 binding and combined CD28 costimulation: the work from Hui and others suggests that …
PD-1 binding and combined CD28 costimulation: the work from Hui and others suggests that …
Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis
… Edwin Pun Hui, MD Edwin Pun Hui … We searched for trials in electronic publication
databases, trial registries, and meeting proceedings (details in appendix). …
databases, trial registries, and meeting proceedings (details in appendix). …
Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab
…, FKF Mo, MT Chu, HLY Chan, EP Hui… - Journal of Clinical …, 2009 - ascopubs.org
Purpose Reactivation of hepatitis B virus (HBV) infection is a well-recognized complication in
cancer patients with chronic HBV (hepatitis B surface antigen [HBsAg] positive) undergoing …
cancer patients with chronic HBV (hepatitis B surface antigen [HBsAg] positive) undergoing …
Overall survival after concurrent cisplatin–radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma
…, PML Teo, WH Lau, WH Kwan, EP Hui… - Journal of the …, 2005 - academic.oup.com
This phase III randomized study compared concurrent cisplatin–radiotherapy (CRT) versus
radiotherapy (RT) alone in patients with locoregionally advanced nasopharyngeal carcinoma…
radiotherapy (RT) alone in patients with locoregionally advanced nasopharyngeal carcinoma…
Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease
… A, C, and E, were reportedly decreased in AD. We found that curcumin raised vitamin E. One
… for and depletion of the antioxidant vitamin E. Another possibility is that curcumin slows AD …
… for and depletion of the antioxidant vitamin E. Another possibility is that curcumin slows AD …
Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma
Purpose To compare the toxicities, tumor control, survival, and quality of life of nasopharyngeal
cancer (NPC) patients treated with sequential neoadjuvant chemotherapy followed by …
cancer (NPC) patients treated with sequential neoadjuvant chemotherapy followed by …
[HTML][HTML] Analysis of plasma Epstein–Barr virus DNA to screen for nasopharyngeal cancer
…, IOL Tse, SYM Leung, G Chan, EP Hui… - … England Journal of …, 2017 - Mass Medical Soc
Background Circulating cell-free Epstein–Barr virus (EBV) DNA is a biomarker for nasopharyngeal
carcinoma. We conducted a prospective study to investigate whether EBV DNA in …
carcinoma. We conducted a prospective study to investigate whether EBV DNA in …